logo

iStock Rating

A
Details...
Enter Symbol click to research

Human Genome Sciences, Inc. (NASDAQ: HGSI)

Sector: Medical

Current Price : $14.24

52 Week Low
$6.6452 Week High
$21.01
 

HUMAN GENO(NSDQ:HGSI)
Human Genome Sciences is a biopharmaceutical company with a pipeline of novel compounds in clinical development, including drugs to treat such diseases as hepatitis C, lupus, anthrax disease, cancer, rheumatoid arthritis and HIV/AIDS. Additional products are in clinical development by companies with which we are collaborating. Its mission is to discover, develop, manufacture and market innovative drugs that serve patients with unmet medical needs, with a primary focus on protein and antibody products.
# Employees: 1100
Address: 14200 SHADY GROVE ROAD,ROCKVILLE,MD,USA
Phone: 3013098504
Fax: 301-309-8512
Website: http://www.hgsi.com
Email: investor_Relations@hgsi.com
Sector: Medical
Industry: MED-BIOMED/GENE
Executive Officers
Argeris N. Karabelas (Ph.D)
Chairman (H. Thomas Watkins)
Chief Executive Officer (David P. Southwell)
Chief Financial Officer (Allan Baxter)
Ph.D (Director,Richard J. Danzig ,Director,)
Dividend
Ex-Dividend Date: N/A
Annual Dividend: N/A
Current Dividend Yield: N/A
Dividend Paid (3 months): N/A
Indicated Dividend: N/A
Earnings
Last Earnings Date: 3/31/2012
Next Earnings Date(Expected): 7/24/2012
Mean EPS (Next Qtr): ($0.36)
Mean EPS (Year): ($1.54)
Mean Estimate(Long Term): ($0.01)
P/E Ratio(Based on EPS estimate): -0.010
Number of Estimates: 13
Shares Performance
Period hgsi Compare to S&P
YTD 92.69 % 74.97 %
4 Weeks 8.45 % 6.21 %
12 Weeks -0.90 % -2.46 %
Shares Information
Analyst Coverage: Y
Avg Volume: 11758531
Shares Outstanding: 199M
Market Cap: $2.83B
52 Week High: $21.01
52 Week Low: $6.64
P/E Ratio: -0.010
PEG Ratio: -0.010
Split: On 10/6/2000 hgsi split by factor of 2.000
Earnings Performance
EPS Growth in Last Quarter: -14.63 %
EPS Growth in Last Year: 31.88 %
Sales Growth in Last Quarter: 3.53 %
Sales Growth in Last Quarter: 77.35 %
Financials
Qtr Book Value: $6.20
Cash Flow/Share: ($0.01)
Change in Payout Ratio: -0.010
Price/Sales: -0.010
Home | Login |Research | Earnings | Scans | Stock Charts | Chart School | Glossary |Submit Article | Join Blog Network | Advertise | Subscribe to RSS

Terms of Use | Privacy Policy | Copyright 2012 all rights reserved
Fundamental data is provided by Zacks Investment Research, and Commentary, news and Press Releases provided by YellowBrix and Quotemedia. Advertisement partners Investing Channel
All information provided "as is" for informational purposes only, not intended for trading purposes or advice. iStockAnalyst.com is not an investment adviser and does not provide, endorse or review any information or data contained herein.
The blog articles are opinions by respective blogger. By using this site you are agreeing to terms and conditions posted on respective bloggers' website.
The postings/comments on the site may or may not be from reliable sources. Neither iStockAnalyst nor any of its independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. You are solely responsible for the investment decisions made by you and the consequences resulting therefrom. By accessing the iStockAnalyst.com site, you agree not to redistribute the information found therein.
The sector scan is based on 15-30 minutes delayed data. The Pattern scan is based on EOD data.